Atlas Trials

Mirvaso in Use Study

Clinical trial NCT02249065 · COMPLETED

Trial details

NCT number
NCT02249065
Sponsor
Galderma R&D
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Rosacea
Start date
2014-09-01
Primary completion
2015-08-01
Enrollment
205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.